News Sentiment

ESPR sentiment intelligence

Esperion Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 35 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 3.18 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 35

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.6% over one week, +1.0% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Wasatch Advisors reports 0.7% Esperion Therapeutics (ESPR) stake

Market Reaction

Balanced read

48/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 0.6% Price digesting
Trend fit Trend inactive 1.0% over four weeks
Fair value 45.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 25
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 35
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
Stocktwits 3
GlobeNewswire 3
Moomoo 2
Market source 2
simplywall.st 2
MT Newswires 2
marketscreener.com 1

Event Lens

What the news is about

Classified themes
Market update 20
Deals and strategy 6
Analyst action 3
Balance sheet 2
Earnings 2
Guidance 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 35